UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 163 filers reported holding UNIQURE NV in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,616,461 | -79.5% | 1,731,216 | -65.0% | 0.00% | -100.0% |
| Q2 2023 | $56,669,436 | -42.8% | 4,944,977 | +0.5% | 0.00% | -33.3% |
| Q1 2023 | $99,092,264 | -12.2% | 4,920,172 | -1.2% | 0.00% | -25.0% |
| Q4 2022 | $112,855,115 | +22.8% | 4,978,170 | +1.6% | 0.00% | +33.3% |
| Q3 2022 | $91,897,000 | +14.7% | 4,898,640 | +14.0% | 0.00% | 0.0% |
| Q2 2022 | $80,128,000 | +1.5% | 4,298,835 | -1.6% | 0.00% | +50.0% |
| Q1 2022 | $78,908,000 | -11.4% | 4,366,736 | +1.7% | 0.00% | 0.0% |
| Q4 2021 | $89,053,000 | -34.4% | 4,293,805 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $135,834,000 | +254.4% | 4,243,498 | +241.0% | 0.00% | +300.0% |
| Q2 2021 | $38,331,000 | -22.4% | 1,244,554 | -15.1% | 0.00% | 0.0% |
| Q1 2021 | $49,394,000 | -0.1% | 1,466,114 | +7.2% | 0.00% | -50.0% |
| Q4 2020 | $49,419,000 | +12.2% | 1,367,853 | +14.4% | 0.00% | 0.0% |
| Q3 2020 | $44,030,000 | +12.0% | 1,195,495 | +37.1% | 0.00% | 0.0% |
| Q2 2020 | $39,296,000 | +22.7% | 872,088 | +29.3% | 0.00% | 0.0% |
| Q1 2020 | $32,016,000 | -19.7% | 674,714 | +21.3% | 0.00% | 0.0% |
| Q4 2019 | $39,853,000 | +98.8% | 556,134 | +9.2% | 0.00% | +100.0% |
| Q3 2019 | $20,045,000 | -49.6% | 509,281 | +0.1% | 0.00% | -50.0% |
| Q2 2019 | $39,766,000 | +47.3% | 508,828 | +12.4% | 0.00% | +100.0% |
| Q1 2019 | $27,005,000 | +100.1% | 452,730 | -3.3% | 0.00% | 0.0% |
| Q4 2018 | $13,495,000 | -22.9% | 468,249 | -2.7% | 0.00% | 0.0% |
| Q3 2018 | $17,507,000 | -0.3% | 481,106 | +3.6% | 0.00% | 0.0% |
| Q2 2018 | $17,555,000 | +71.7% | 464,426 | +6.7% | 0.00% | – |
| Q1 2018 | $10,225,000 | +11.4% | 435,127 | -7.1% | 0.00% | – |
| Q4 2017 | $9,177,000 | +2143.8% | 468,422 | +999.6% | 0.00% | – |
| Q3 2017 | $409,000 | +32.4% | 42,599 | -14.4% | 0.00% | – |
| Q2 2017 | $309,000 | +1445.0% | 49,794 | +1350.0% | 0.00% | – |
| Q1 2017 | $20,000 | +33.3% | 3,434 | +281.6% | 0.00% | – |
| Q4 2015 | $15,000 | +7.1% | 900 | +28.6% | 0.00% | – |
| Q3 2015 | $14,000 | -96.2% | 700 | -97.2% | 0.00% | -100.0% |
| Q4 2014 | $367,000 | +60.3% | 24,800 | 0.0% | 0.00% | – |
| Q3 2014 | $229,000 | -37.1% | 24,800 | -7.5% | 0.00% | -100.0% |
| Q2 2014 | $364,000 | – | 26,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |